European Journal of Gastroenterology & Hepatology

Papers
(The H4-Index of European Journal of Gastroenterology & Hepatology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Paper Alert35
Paper alert33
Effectiveness and safety of newly introduced endoscopic submucosal dissection in a Western center: a real-life study31
String used for oesophageal capsule endoscopy: help or hindrance?29
Quality of care in inflammatory bowel disease from patient’s perspective using QUOTE-IBD: a Greek multicenter prospective study27
Mid- to long-term outcomes of initial transjugular intrahepatic portosystemic shunt versus anticoagulation for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome24
Suppressed serological vitamin A in patients with liver cirrhosis is associated with impaired liver function and clinical detoriation23
Fib-4 index predicts prognosis after achievement of sustained virologic response following direct-acting antiviral treatment in patients with hepatitis C virus infection23
Coexistence of metabolic-associated fatty liver disease and autoimmune or toxic liver disease21
Correlating endoscopic findings with pathology to optimize biopsy strategies in gastritis: insights from a large cohort study20
Association of left ventricular diastolic dysfunction with inflammatory activity, renal dysfunction, and liver-related mortality in patients with cirrhosis and ascites19
Clinical study of probiotics combined with lactulose for minimal hepatic encephalopathy treatment18
SAFE vs. FIB-4: diagnostic accuracy for clinically significant fibrosis in U.S. adults with cardiometabolic risk factors – a NHANES 2017–2020 analysis18
Endoscopic retrograde cholangiopancreatography discharge tool combined with rapid trypsinogen-2 test to predict same-day discharge: a prospective cohort study16
Cardiovascular risk profiles in patients with primary sclerosing cholangitis16
Prevalence and predictors of arthralgia after initiation of vedolizumab in patients with inflammatory bowel disease: a retrospective cohort study16
0.15073800086975